Published in Cancer Law Weekly, June 3rd, 2006
"We have previously shown in a retrospective study that expression of MRP1 is associated with outcome in neuroblastoma. We have now undertaken a prospective analysis to examine the independent prognostic significance of MRP1 expression in a large cohort of primary untreated neuroblastomas," wrote M. Haber and colleagues, Children's Cancer Institute of Australia.
"Two hundred nine diagnostic neuroblastoma samples from patients prospectively...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.